About This Site
joe-tippens-protocol.com is an independent, educational website that reviews the public claims, published research, and documented safety concerns around the so-called “Joe Tippens Protocol” — the fenbendazole-based regimen that went viral after a Oklahoma businessman credited it with his recovery from small cell lung cancer.
Who runs this site
This site is written and maintained by Baiyang Chen, Shanghai, China. I am an independent health-information researcher and writer, and I have no medical degree. I do not give medical advice, and no article on this site should be read as a recommendation to start, stop, or change any treatment.
Why the domain mentions Joe Tippens
We registered this domain because “Joe Tippens protocol” is the phrase people actually search for when they want to understand this topic. The domain name implies no relationship we do not have. To be completely clear: this site is not affiliated with, endorsed by, or connected to Joe Tippens, his family, or mycancerstory.rocks. We quote his public statements the way a journalist quotes any public figure — with attribution and links to the original source.
What we publish
- Evidence reviews that separate laboratory research, animal studies, case reports, and clinical trials — and explain why those categories are not interchangeable.
- Safety reporting: regulatory warnings, documented adverse events, and known risks, cited to primary sources such as the FDA and peer-reviewed literature.
- A documented, sourced timeline of the Joe Tippens story and how it spread.
- Practical guides that help patients and caregivers evaluate treatment claims, find legitimate clinical trials, and prepare better questions for their oncologists.
Editorial standards
Every factual claim is tied to a cited source: regulatory agencies, peer-reviewed journals, clinical trial registries, or the primary documents themselves. We deliberately do not publish doses, schedules, or “how to take it” instructions for fenbendazole or any other drug, because no safe or effective human dose for cancer has ever been established in a controlled trial. When our reporting turns out to be wrong or outdated, we correct the article and note the change at the bottom of the page. You can report errors via our contact page.
Funding
This site is funded by display advertising served through Google AdSense. We do not sell products, do not use affiliate links, and do not accept sponsored articles or paid placements. Advertisers have no influence over editorial content, and we do not write articles to match advertisers.
Updates
Health evidence changes. We review our core articles at least twice a year and whenever a major regulatory statement or peer-reviewed study is published. Each article shows its last-updated date.
See also our Privacy Policy, Terms of Use, and Medical Disclaimer.